GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $4,581,000 | -61.6% | 179,806 | -47.2% | 0.04% | -58.6% |
Q2 2021 | $11,922,000 | -67.0% | 340,432 | -61.6% | 0.09% | -68.1% |
Q1 2021 | $36,117,000 | +520.5% | 886,300 | +861.3% | 0.27% | +425.0% |
Q2 2020 | $5,821,000 | +115.5% | 92,201 | +74.4% | 0.05% | +73.3% |
Q1 2020 | $2,701,000 | -74.6% | 52,859 | -60.6% | 0.03% | -62.0% |
Q4 2019 | $10,652,000 | +258.8% | 134,000 | +119.0% | 0.08% | +243.5% |
Q3 2019 | $2,969,000 | -10.8% | 61,184 | -3.3% | 0.02% | -8.0% |
Q2 2019 | $3,328,000 | -64.1% | 63,268 | -67.0% | 0.02% | -62.7% |
Q1 2018 | $9,268,000 | – | 191,890 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |